GlassScriptPhysician profile
Vonda R Ware
NPI 1144286865
$957.33
in general payments reported to CMS, 2019-2025
21 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $45.90 · 2021: $81.60 · 2022: $170 · 2023: $13.51 · 2024: $51.60 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $170.93 | 2019-2021 | |
| Hologic Sales and Service, LLC | $170.46 | 2022 | |
| Neurocrine Biosciences, INC. | $107.08 | 2025 | |
| Lilly USA, LLC | $55.44 | 2025 | Zepbound, Mounjaro |
| Therapeuticsmd, INC. | $52.99 | 2019 | |
| Coloplast Corp | $47.63 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.31 | 2019 | |
| Astellas Pharma US INC | $37.51 | 2019-2024 | Veozah |
| Lupin INC. | $33.72 | 2019 | |
| Argenx US, INC. | $31.14 | 2024 | Vyvgart Hytrulo, Vyvgart |
| Abbott Laboratories | $30.62 | 2025 | Infinity |
| Allergan, INC. | $27.75 | 2019 | |
| Sanofi Pasteur INC. | $23.22 | 2025 | |
| Ethicon US, LLC | $18.77 | 2019 | |
| Amgen INC. | $17.39 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.14 | 2025 | Arexvy, Shingrix |
| Roche Diagnostics Corporation | $16.80 | 2019 | |
| Merck Sharp & Dohme LLC | $15.84 | 2019 | |
| Daiichi Sankyo INC. | $14.72 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.51 | 2023 | Austedo |
| Amag Pharmaceuticals, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vonda Ware listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.